| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021476 High Affinity Human Antibodies to Human IL-4 Receptor |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021464 Methods of wound care and treatment |
| 01/28/2010 | US20100021415 Cosmetic use of organic resinates |
| 01/28/2010 | US20100021401 Method for treating skin |
| 01/28/2010 | US20100021399 Cosmetic or dermatological preparations comprising n-acetylcysteine |
| 01/28/2010 | DE102008035442A1 Zubereitungen aus Artemisia Annua, ihre Umwandlung in Mikro- und Nanopartikel und ihre Verwendung Preparations from Artemisia annua, their conversion into micro- and nanoparticles and their use |
| 01/28/2010 | DE102008034265A1 Wirkstoffkombination aus Anisfruchtextrakt und Hyaluronsäure Active ingredient combination of anise fruit and hyaluronic acid |
| 01/28/2010 | CA2731501A1 Transdermal pharmaceutical compositions comprising danazol |
| 01/28/2010 | CA2731445A1 Topical anti-inflammatory combination |
| 01/27/2010 | EP2147922A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/27/2010 | EP2147675A1 Agent for stimulating lymphatic drainage |
| 01/27/2010 | EP2147674A1 Transdermal pharmaceutical compositions comprising danazol |
| 01/27/2010 | EP2147673A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 01/27/2010 | EP2146989A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/27/2010 | EP2146951A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 01/27/2010 | EP2146738A2 Wound healing compositions containing keratin biomaterials |
| 01/27/2010 | EP2146726A1 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions |
| 01/27/2010 | EP2146710A1 P38alpha as a therapeutic target in bladder carcinoma |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100584857C Process of high purity albumin production |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584376C Medicine for treating deep erosive trauma with crust |
| 01/27/2010 | CN100584375C Formula for treating scar |
| 01/27/2010 | CN100584365C Pharmaceutical composition for treating acne |
| 01/27/2010 | CN100584361C Medicine composition for relieving perniosis and itching |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652000 Antibiotics incorporating borinic acid complexes; (bis(3-chloro-4-methylphenyl)boryloxy)(3-hydroxypyridin-2-yl)methanone; Antiinflammatory drugs; enhanced stability |
| 01/26/2010 | US7651700 Topical diclofenac patch |
| 01/26/2010 | US7651698 Prolonged release bioadhesive therapeutic systems |
| 01/26/2010 | US7651692 Skin disorders; cosmetics; aging resistance |
| 01/26/2010 | US7651681 Method and compositions for in situ formation of protective and/or medicated films on body tissue |
| 01/26/2010 | CA2494001C Use of a chrysanthellum extract |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2426852C Formulation containing phosphate derivatives of electron transfer agents |
| 01/26/2010 | CA2213500C Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/21/2010 | WO2010009405A2 Targeted nitroxide agents |
| 01/21/2010 | WO2010009369A2 Methods and materials for the treatment of acne |
| 01/21/2010 | WO2010009129A2 Methods of treating autoimmune diseases using cd4 antibodies |
| 01/21/2010 | WO2010008733A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | WO2010008573A2 Wound healing |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007252A2 Formulation for improving the bioavailability of a hydrophobic molecule |
| 01/21/2010 | WO2010007175A2 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 01/21/2010 | WO2010006962A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 01/21/2010 | WO2010006792A1 Synthesis of cyclic amidines |
| 01/21/2010 | WO2010006442A1 Articles of manufacture releasing an active ingredient |
| 01/21/2010 | WO2010006412A1 Cosmetic compositions comprising asteroidea body fluid and methods of use thereof |
| 01/21/2010 | WO2009144744A3 Compositions comprising euphorbia prostrata and process of preparation thereof |
| 01/21/2010 | WO2009138706A3 Compositions based on porous polymer/hydrogen peroxide complexes and uses thereof |
| 01/21/2010 | WO2009134967A3 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 01/21/2010 | WO2009134383A3 Vinyl substituted fatty acids |
| 01/21/2010 | WO2009103319A3 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 01/21/2010 | WO2009091764A3 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 01/21/2010 | US20100016783 Non-invasive systems and methods for in-situ photobiomodulation |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016446 Stable water-based topical pharmaceutical creams and methods of making and using same |
| 01/21/2010 | US20100016443 Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 01/21/2010 | US20100016430 Modified coconut oils with broad antimicrobial spectrum |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016357 Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorders and Pain |
| 01/21/2010 | US20100016344 Amino heterocyclic linked pyrimidine derivatives |
| 01/21/2010 | US20100016290 Amorphous polymorph of bazedoxifene acetate |
| 01/21/2010 | US20100016271 Anti-dandruff hair conditioning compositions |
| 01/21/2010 | US20100016263 9, 10-secopregnane derivative and pharmaceutical |
| 01/21/2010 | US20100016243 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015262 Novel use of compounds and combinations of compounds for improving the physical appearance |
| 01/21/2010 | US20100015257 Composition For Treating Atopic Dermatitis Comprising Extracts Of Bamboo And Scutellaria |
| 01/21/2010 | US20100015253 Treatment of nail infections with no |
| 01/21/2010 | US20100015242 Use of a composition for skin treatment under x-irradiation |
| 01/21/2010 | US20100015208 Antibacterial wound dressing |
| 01/21/2010 | US20100015162 treating interleukin-22 (IL-22)-associated disorder such as arthritis or psoriasis by administering the antibody in an amount sufficient to inhibit or reduce immune cell activity in the subject |
| 01/21/2010 | US20100015119 Epithelium-improving agent |
| 01/21/2010 | US20100015110 Fermented milk for skin improvement and/or treatment and process for producing the same |
| 01/21/2010 | US20100015080 Use of at least one (dihydro)jasmonic acid derivative for treating dry skin |
| 01/21/2010 | US20100012132 Clear, washable lubricant compositions, and methods of making same |
| 01/21/2010 | DE102008015425A1 Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid Cosmetic or dermatological preparations to reduce itching and other dermatological abnormal sensations that can occur with aging skin in particular, with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridin-2- yl) ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid |
| 01/21/2010 | CA2768183A1 Targeted nitroxide agents |
| 01/21/2010 | CA2765373A1 Cosmetic compositions comprising asteroidea body fluid and methods of use thereof |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730615A1 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 01/21/2010 | CA2730534A1 Formulation for improving the bioavailability of a hydrophobic molecule |
| 01/21/2010 | CA2730477A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |